Cargando…
Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
Oxidation of low-density lipoprotein (LDL) is thought to contribute to atherosclerosis and cardiovascular disease. Consistent with this idea, the antioxidant drug probucol reduces the risk of restenosis, a form of cardiovascular disease, in humans. However, a new study now suggests that the protecti...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
The Rockefeller University Press
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118281/ https://www.ncbi.nlm.nih.gov/pubmed/16606677 http://dx.doi.org/10.1084/jem.20060218 |